Millipore Sigma Vibrant Logo

HTS216M ChemiSCREEN™ Membrane Preparation Recombinant Human α1D Adrenergic Receptor with N-terminal truncation

View This Product on Sigma-Aldrich
HTS216M
200 units  
価格を検索中…
価格が見つかりません
Minimum Quantity needs to be mulitiple of
Maximum Quantity is
弊社照会 詳細を表示 
値引
()
 
弊社照会
現在国内在庫なし
現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

       

      お問合せください

      概要

      Replacement Information

      主要スペック表

      SpeciesHost CellsProtein Target
      Human Chem-1alpha1D
      Description
      Catalogue NumberHTS216M
      Trade Name
      • ChemiScreen
      • Chemicon
      DescriptionChemiSCREEN™ Membrane Preparation Recombinant Human α1D Adrenergic Receptor with N-terminal truncation
      OverviewTruncated human ADRA1D cDNA encoding α1D lacking residues 2-79
      Background InformationThe endogenous catecholamines epinephrine and norepinephrine have profound effects on smooth muscle activity, cardiac function, carbohydrate and fat metabolism, hormone secretion, neurotransmitter release, and central nervous system actions. These activities are mediated by GPCRs belonging to two subfamilies, the α- and β-adrenoceptors (Bylund et al., 1994). The three members of the α1 subclass of adrenoceptors, α1A, α1B and α1D, couple to Gq, and promote contraction of vascular and urinary tract smooth muscle, relaxation of intestinal smooth muscle, increased contractile force in the heart, and glycogenolysis and gluconeogenesis in the liver. The different subtypes have overlapping distributions and variably contribute to these effects depending on species and tissue. The α1D adrenergic receptor mediates smooth muscle contraction in several tissues. In the vasculature, activation of α1D increases blood pressure (Tanoue et al., 2002; Hosoda et al., 2005). In the urinary tract, α1D promotes bladder contraction. Antagonists of α1 receptors are used to treat bladder outlet obstruction, and this effect is thought to be mediated by α1D (Chen et al., 2005). The α1D adrenergic receptors has a relatively long N-terminal extracellular domain, and truncation of this domain has been shown to increase expression of the receptor at the cell surface (Pupo et al., 2003). Millipore's α1D membrane preparations, which contain a version of α1D lacking residues 2-79, are crude membrane preparations made from our proprietary stable recombinant cell lines to ensure high-level of GPCR surface expression; thus, they are ideal HTS tools for screening of agonists and antagonists of α1D. The membrane preparations exhibit a Kd of 0.4 nM for [3H]-prazosin. With 0.5 nM [3H]-prazosin, 5 µg/well α1D (Δ2-79) Membrane Prep typically yields greater than 5-fold signal-to-background ratio.
      References
      Product Information
      FormatMembranes
      PresentationLiquid in packaging buffer: 50 mM Tris pH 7.4, 10% glycerol and 1% BSA no preservatives.
      Packaging method: Membranes protein adjusted to the indicated concentration in packaging buffer, rapidly frozen, and stored at -80°C.
      Quality LevelMQ100
      Applications
      ApplicationHuman alpha1D GPCR membrane preparation for Radioligand binding Assays & GTPγS binding.
      Key Applications
      • Radioligand binding assay
      • GTPγS binding
      Application NotesRadioligand binding assay and GTPγS binding.
      Biological Information
      Entrez Gene Number
      Gene Symbol
      • ADRA1D
      • ADRA1A
      GPCR ClassA
      Host CellsChem-1
      Protein Targetalpha1D
      Target Sub-FamilyAdrenergic
      UniProt Number
      Incubation ConditionsRECOMMENDED ASSAY CONDITIONS: Membranes are mixed with radioactive ligand and unlabeled competitor (see Figures 1 and 2 for concentrations tested) in binding buffer in a nonbinding 96-well plate, and incubated for 1-2 h. Prior to filtration, an FC 96-well harvest plate (Millipore cat. # MAHF C1H) is coated with 0.33% polyethyleneimine for 30 min, then washed with 50mM HEPES, pH 7.4, 0.5% BSA. Binding reaction is transferred to the filter plate, and washed 3 times (1 mL per well per wash) with Wash Buffer. The plate is dried and counted.

      Binding buffer: 50 mM Hepes, pH 7.4, 5 mM MgCl2, 1 mM CaCl2, 0.2% BSA, filtered and stored at 4°C

      Radioligand: [3H]-prazosin. (PerkinElmer NET-823 )

      Wash Buffer: 50 mM Hepes, pH 7.4, 500mM NaCl , 0.1% BSA, filtered and stored at 4°C.

      One package contains enough membranes for at least 200 assays (units), where a unit is the amount of membrane that will yield greater than 5-fold signal:background with 3H labeled prazosin at 0.5 nM
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Table 1. Signal:background and specific binding values obtained in a competition binding assay with varying amounts of α1D (Δ2-79) receptor membrane prep.
      Product Usage Statements
      10 µg/well 5 µg/well
      Signal:Background 15.4 11.2
      Specific Binding (cpm) 778.8 670.5

      SPECIFICATIONS: 1 unit = 5 µg membrane preparation
      Bmax for [3H]-prazosin binding: 4.23 pmol/mg protein
      Kd for [3H]-prazosin binding: ~0.4 nM Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsMaintain frozen at -70°C. Product is stable for at least 6 months from the date of receipt when stored as directed. Do not freeze and thaw.
      Packaging Information
      Material Size200 units
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      HTS216M 04053252738104

      Documentation

      ChemiSCREEN™ Membrane Preparation Recombinant Human α1D Adrenergic Receptor with N-terminal truncation (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      参考資料

      参考資料の概要Pub Med ID
      Function of the lower urinary tract in mice lacking alpha1d-adrenoceptor.
      Chen, Qin, et al.
      J. Urol., 174: 370-4 (2005)  2005

      15947692 15947692
      Two alpha1-adrenergic receptor subtypes regulating the vasopressor response have differential roles in blood pressure regulation.
      Hosoda, Chihiro, et al.
      Mol. Pharmacol., 67: 912-22 (2005)  2005

      概要を表示する
      15598970 15598970
      N-terminal truncation of human alpha1D-adrenoceptors increases expression of binding sites but not protein.
      Pupo, Andre S, et al.
      Eur. J. Pharmacol., 462: 1-8 (2003)  2003

      12591089 12591089
      The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction.
      Tanoue, Akito, et al.
      J. Clin. Invest., 109: 765-75 (2002)  2002

      11901185 11901185
      Selectivity of the imidazoline alpha-adrenoceptor agonists (oxymetazoline and cirazoline) for human cloned alpha 1-adrenoceptor subtypes.
      Horie, K, et al.
      Br. J. Pharmacol., 116: 1611-8 (1995)  1995

      8564227 8564227

      データシート

      タイトル
      CHEMISCREEN™ MEMBRANE PREPARATION RECOMBINANT HUMAN a1D ADRENERGIC RECEPTOR with N-terminal truncation

      関連製品&アプリケーション

      製品ファミリー

      関連製品: Brand Facete

      カテゴリー

      Life Science Research > Drug Discovery and Development > GPCR Cell Lines & Assays > GPCR Membrane Preparations
      Life Science Research > タンパク質と酵素 > GPCR Membrane Preparations